Attacks on Hospitals and Health Workers Threaten Healthcare Delivery in Lebanon
Escalating Attacks on Healthcare Threaten Health Services in Lebanon Amid Conflict Since hostilities between Israel and Lebanon intensified on September 17, 2024, WHO has confirmed 23 attacks on healthcare in…
Enhancing Biological Specimen Shipping for Faster Disease Detection and Response
Strengthening the Shipping of Biological Specimens for Rapid Disease Detection and Response Since 2016, the WHO Global Influenza Program (GIP) has been supporting the United Nations Food and Agriculture Organization…
Yemen Starts Sharing Seasonal Influenza Viruses with WHO Centre in London
Influenza Virus Sharing Essential for Pandemic Preparedness: Yemen Achieves Milestone with WHO Collaboration Virus sharing is crucial for global pandemic preparedness, enabling the development of vaccine candidates, monitoring antiviral resistance,…
Elanco’s Parvovirus Antibody Boosts Puppy Survival, Eases Vet Clinic Strain
Elanco’s Parvovirus Antibody Treatment Saves Thousands of Puppies in First Year Elanco Animal Health has released the first real-world data showcasing the effectiveness of its Canine Parvovirus Monoclonal Antibody (CPMA),…
Lupin Introduces First Generic Version of Pred Forte® in the U.S.
Lupin Launches First Generic Pred Forte® Ophthalmic Suspension in the U.S. Prednisolone Acetate Ophthalmic Suspension Marks First Generic Launch with 180-Day CGT Exclusivity Mumbai, Naples, October 15, 2024: Lupin Limited,…
Novotech Earns Prestigious US Great Place to Work® Certification
Novotech, a full-service international clinical contract research organization (CRO), is proud to announce its recognition as a U.S. Great Place to Work® certified company. This prestigious certification underscores Novotech’s commitment…
bit.bio Secures Major Patent Victory for Revolutionary opti-ox™ Cell Programming Technology
bit.bio has successfully defended its European patent for the groundbreaking opti-ox™ technology, which facilitates the precise programming of pluripotent stem cells (PSCs), including induced pluripotent stem cells (iPSCs), into any…
Marinus Pharmaceuticals Expands Intellectual Property with New Patent for ZTALMY® Titration Methods
Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a company focused on developing innovative treatments for seizure disorders, announced the addition of a new patent to its intellectual property portfolio. The United States…
Anthem Blue Cross and Open Table Launch Initiative to Tackle Youth Substance Use Disorder
As part of a three-year, $30 million initiative focused on mental health and well-being, the Anthem Blue Cross and Blue Shield Foundation has launched a new program in Shenandoah County,…
UroGen Announces FDA Acceptance of New Drug Application for UGN-102
PDUFA Goal Date Set for June 13, 2025: UGN-102 Could Be First FDA-Approved Treatment for LG-IR-NMIBC UroGen Pharma Ltd. (Nasdaq: URGN), a biotechnology company committed to developing innovative solutions for…
FDA Approves Novocure’s Optune Lua® for Metastatic Non-Small Cell Lung Cancer Treatment
FDA Approves Optune Lua® as First-of-its-Kind Treatment for Metastatic Non-Small Cell Lung Cancer Novocure (NASDAQ: NVCR) announced that the U.S. Food and Drug Administration (FDA) has approved Optune Lua®, a…
Lenovo Launches First AI Avatar for Alzheimer’s and Dementia Care
At Lenovo Tech World, Lenovo™, in collaboration with Innovations in Dementia, launched “Alzheimer’s Intelligence,” a photorealistic 3D avatar powered by AI, designed to support individuals and families affected by dementia…